Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (161-170 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|December 25, 2013
A study of the immune properties of human umbilical cord lining epithelial cellsYi-Jun Cai, Lin Huang, Tak-Yeung Leung, et al.
Cytotherapy|December 31, 2013
Does plerixafor destroy the hematopoietic progenitor cell/mesenchymal stromal cell niche?Ian McNiece, Elizabeth Shpall
Cytotherapy|November 2, 2013
Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years oldCristina Motlló, Juan-Manuel Sancho, Joan-Ramon Grífols, et al.
Cytotherapy|November 2, 2013
Ascorbic acid induces osteoblast differentiation of human suspension mononuclear cellsSiti Norhaiza Hadzir, Siti Norsaidah Ibrahim, Rohaya Megat Abdul Wahab, et al.
Cytotherapy|March 19, 2021
Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic miceBing Li, Yu Cheng, Yaqi Yin, et al.
Cytotherapy|September 4, 2022
Hypothesis: can transfer of primary neoplasm-derived extracellular vesicles and mitochondria contribute to the development of donor cell-derived hematologic neoplasms after allogeneic hematopoietic cell transplantation?Masahiro Imamura
Cytotherapy|January 21, 2022
Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host diseaseAnna Kroeze, Vera van Hoeven, Myrddin W Verheij, et al.
Cytotherapy|November 9, 2021
An industry survey of implementation strategies for clinical supply chain management of cell and gene therapiesLequina Myles, Terry David Church
Cytotherapy|November 10, 2021
Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experiencePatrick J Hanley, Alexey Bersenev, Michael P Gustafson
Cytotherapy|November 10, 2021
CAR-T cell therapy in India requires a paradigm shift in training, education and health care processesAkshay Ravindranath, Aparajita Dubey, Surekha Suresh, et al.
Pageof 314

Showing results (161-170 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|December 25, 2013
A study of the immune properties of human umbilical cord lining epithelial cellsYi-Jun Cai, Lin Huang, Tak-Yeung Leung, et al.
Cytotherapy|December 31, 2013
Does plerixafor destroy the hematopoietic progenitor cell/mesenchymal stromal cell niche?Ian McNiece, Elizabeth Shpall
Cytotherapy|November 2, 2013
Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years oldCristina Motlló, Juan-Manuel Sancho, Joan-Ramon Grífols, et al.
Cytotherapy|November 2, 2013
Ascorbic acid induces osteoblast differentiation of human suspension mononuclear cellsSiti Norhaiza Hadzir, Siti Norsaidah Ibrahim, Rohaya Megat Abdul Wahab, et al.
Cytotherapy|March 19, 2021
Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic miceBing Li, Yu Cheng, Yaqi Yin, et al.
Cytotherapy|September 4, 2022
Hypothesis: can transfer of primary neoplasm-derived extracellular vesicles and mitochondria contribute to the development of donor cell-derived hematologic neoplasms after allogeneic hematopoietic cell transplantation?Masahiro Imamura
Cytotherapy|January 21, 2022
Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host diseaseAnna Kroeze, Vera van Hoeven, Myrddin W Verheij, et al.
Cytotherapy|November 9, 2021
An industry survey of implementation strategies for clinical supply chain management of cell and gene therapiesLequina Myles, Terry David Church
Cytotherapy|November 10, 2021
Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experiencePatrick J Hanley, Alexey Bersenev, Michael P Gustafson
Cytotherapy|November 10, 2021
CAR-T cell therapy in India requires a paradigm shift in training, education and health care processesAkshay Ravindranath, Aparajita Dubey, Surekha Suresh, et al.
Pageof 314